227 related articles for article (PubMed ID: 10382974)
1. Advanced glycation end-products in diabetic nephropathy.
Friedman EA
Nephrol Dial Transplant; 1999; 14 Suppl 3():1-9. PubMed ID: 10382974
[TBL] [Abstract][Full Text] [Related]
2. The importance of diabetic nephropathy in current nephrological practice.
Locatelli F; Canaud B; Eckardt KU; Stenvinkel P; Wanner C; Zoccali C
Nephrol Dial Transplant; 2003 Sep; 18(9):1716-25. PubMed ID: 12937216
[TBL] [Abstract][Full Text] [Related]
3. Design and baseline characteristics for the aminoguanidine Clinical Trial in Overt Type 2 Diabetic Nephropathy (ACTION II).
Freedman BI; Wuerth JP; Cartwright K; Bain RP; Dippe S; Hershon K; Mooradian AD; Spinowitz BS
Control Clin Trials; 1999 Oct; 20(5):493-510. PubMed ID: 10503809
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia in the diabetic kidney is independent of advanced glycation end-products.
Nordquist L; Liss P; Fasching A; Hansell P; Palm F
Adv Exp Med Biol; 2013; 765():185-193. PubMed ID: 22879032
[TBL] [Abstract][Full Text] [Related]
5. Effects of aminoguanidine in preventing experimental diabetic nephropathy are related to the duration of treatment.
Soulis T; Cooper ME; Vranes D; Bucala R; Jerums G
Kidney Int; 1996 Aug; 50(2):627-34. PubMed ID: 8840295
[TBL] [Abstract][Full Text] [Related]
6. Advanced glycation end products and diabetic nephropathy.
Thomas MC; Forbes JM; Cooper ME
Am J Ther; 2005; 12(6):562-72. PubMed ID: 16280650
[TBL] [Abstract][Full Text] [Related]
7. Diabetic nephropathy: improving prognosis.
Friedman EA
Saudi J Kidney Dis Transpl; 2002; 13(3):281-310. PubMed ID: 18209425
[TBL] [Abstract][Full Text] [Related]
8. ALT-946 and aminoguanidine, inhibitors of advanced glycation, improve severe nephropathy in the diabetic transgenic (mREN-2)27 rat.
Wilkinson-Berka JL; Kelly DJ; Koerner SM; Jaworski K; Davis B; Thallas V; Cooper ME
Diabetes; 2002 Nov; 51(11):3283-9. PubMed ID: 12401720
[TBL] [Abstract][Full Text] [Related]
9. Aminoguanidine prolongs survival in azotemic-induced diabetic rats.
Friedman EA; Distant DA; Fleishhacker JF; Boyd TA; Cartwright K
Am J Kidney Dis; 1997 Aug; 30(2):253-9. PubMed ID: 9261037
[TBL] [Abstract][Full Text] [Related]
10. Advanced glycation endproducts and diabetic nephropathy.
Makita Z; Yanagisawa K; Kuwajima S; Yoshioka N; Atsumi T; Hasunuma Y; Koike T
J Diabetes Complications; 1995; 9(4):265-8. PubMed ID: 8573743
[TBL] [Abstract][Full Text] [Related]
11. Clinical studies of advanced glycation end product inhibitors and diabetic kidney disease.
Williams ME
Curr Diab Rep; 2004 Dec; 4(6):441-6. PubMed ID: 15539009
[TBL] [Abstract][Full Text] [Related]
12. Salvianolic Acid A Protects Against Diabetic Nephropathy through Ameliorating Glomerular Endothelial Dysfunction via Inhibiting AGE-RAGE Signaling.
Hou B; Qiang G; Zhao Y; Yang X; Chen X; Yan Y; Wang X; Liu C; Zhang L; Du G
Cell Physiol Biochem; 2017; 44(6):2378-2394. PubMed ID: 29262395
[TBL] [Abstract][Full Text] [Related]
13. Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathy.
Bolton WK; Cattran DC; Williams ME; Adler SG; Appel GB; Cartwright K; Foiles PG; Freedman BI; Raskin P; Ratner RE; Spinowitz BS; Whittier FC; Wuerth JP;
Am J Nephrol; 2004; 24(1):32-40. PubMed ID: 14685005
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis of diabetic nephropathy.
Raptis AE; Viberti G
Exp Clin Endocrinol Diabetes; 2001; 109 Suppl 2():S424-37. PubMed ID: 11460589
[TBL] [Abstract][Full Text] [Related]
15. Loganin attenuates diabetic nephropathy in C57BL/6J mice with diabetes induced by streptozotocin and fed with diets containing high level of advanced glycation end products.
Liu K; Xu H; Lv G; Liu B; Lee MK; Lu C; Lv X; Wu Y
Life Sci; 2015 Feb; 123():78-85. PubMed ID: 25623853
[TBL] [Abstract][Full Text] [Related]
16. Pimagedine: a novel therapy for diabetic nephropathy.
Abdel-Rahman E; Bolton WK
Expert Opin Investig Drugs; 2002 Apr; 11(4):565-74. PubMed ID: 11922864
[TBL] [Abstract][Full Text] [Related]
17. Diabetic nephropathy--prevention and treatment.
Agarwal DK
J Indian Med Assoc; 2002 Mar; 100(3):158-60, 162-3. PubMed ID: 12408275
[TBL] [Abstract][Full Text] [Related]
18. Renal disease and hypertension in non-insulin-dependent diabetes mellitus.
Ismail N; Becker B; Strzelczyk P; Ritz E
Kidney Int; 1999 Jan; 55(1):1-28. PubMed ID: 9893112
[TBL] [Abstract][Full Text] [Related]
19. Chrysin Inhibits Advanced Glycation End Products-Induced Kidney Fibrosis in Renal Mesangial Cells and Diabetic Kidneys.
Lee EJ; Kang MK; Kim DY; Kim YH; Oh H; Kang YH
Nutrients; 2018 Jul; 10(7):. PubMed ID: 29987200
[TBL] [Abstract][Full Text] [Related]
20. Advanced glycation end-products in diabetic nephropathy.
Sugiyama S; Miyata T; Horie K; Iida Y; Tsuyuki M; Tanaka H; Maeda K
Nephrol Dial Transplant; 1996; 11 Suppl 5():91-4. PubMed ID: 9044316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
